NASDAQ:NXL

Nexalin Technology Q2 2025 Earnings Results & Report

Nexalin Technology logo
$1.44 -0.06 (-4.00%)
Closing price 11/18/2026 03:58 PM Eastern
Extended Trading
$1.51 +0.07 (+4.86%)
As of 11/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nexalin Technology beat analyst expectations on both earnings and revenue in its Q2 2025 results, released August 6, 2025. The company reported EPS of -$3.00 versus the -$4.20 consensus estimate, while revenue of $70 thousand topped the $35 thousand estimate by $35 thousand.

Earnings Announcement Details

Quarter
Q2 2025
Report Date
Time
Before Market Opens
Conference Call
8:00 AM ET

Nexalin Technology EPS Results

Actual EPS
-$3.00
Consensus EPS
-$4.20
Beat/Miss
Beat by +$1.20
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 7 quarters

Nexalin Technology Revenue Results

Actual Revenue
$70 thousand
Expected Revenue
$35 thousand
Beat/Miss
Beat by +$35.00 thousand
YoY Revenue Growth
N/A

Earnings Documents

Nexalin Technology Q2 2025 Earnings FAQ

Nexalin Technology (NASDAQ:NXL) reported earnings of -$3.00 per share for Q2 2025, beating the consensus estimate of -$4.20. The report was announced on Wednesday, August 6, 2025.

Nexalin Technology reported revenue of $70 thousand for Q2 2025, against a consensus estimate of $35 thousand.

Nexalin Technology Earnings Headlines

Pentagon magnet restrictions take effect January 1, 2027
A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It would build and operate a rare earth processing facility on an active military base, with the Army receiving first right to production. The timing matters. New Pentagon restrictions on certain Chinese-origin rare earth magnets take effect January 1, 2027, while China controls more than 90% of global rare earth processing. The company's mine-to-magnet platform spans feedstock agreements, processing facilities, metallization technology, and downstream manufacturing, with initial commercial output targeted for 2027.tc pixel
NXL - Nexalin Technology, Inc.
See More Nexalin Technology Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nexalin Technology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nexalin Technology and other key companies, straight to your email.

About Nexalin Technology

Nexalin Technology (NASDAQ:NXL) develops non-invasive neurostimulation devices for behavioral health applications. Its technology delivers low-level electrical signals through electrodes placed on the head, with the aim of supporting care for conditions such as anxiety, depression and insomnia.

The company’s product line includes its Gen-2 and Gen-3 cranial electrotherapy stimulation devices. Nexalin focuses on developing and commercializing these systems for use by healthcare providers and patients, and has pursued regulatory clearances and distribution opportunities in the United States and international markets.

View Nexalin Technology Profile